# Sustained Transcriptional Response to Lipopolysaccharide and Interleukin-4 in an Immortalized Mouse Microglial Cell Line

**Authors:** Amanda Herrero-González, Alba Puente-Sanz, Diego Pérez-Rodríguez, Berta Anuncibay-Soto, Michal Letek, Marta Regueiro-Purriños, Arsenio Fernández-López

PMC · DOI: 10.1007/s12035-026-05711-4 · Molecular Neurobiology · 2026-02-06

## TL;DR

This study identifies sustained gene responses in microglial cells to inflammation and anti-inflammation, offering insights into microglial states and potential therapeutic targets.

## Contribution

The study introduces a novel classification of microglial transcriptional responses and proposes opposite responder genes as metabolic switches between microglial states.

## Key findings

- RNA sequencing identified four gene sets with distinct responses to LPS and IL-4.
- LPS upregulates innate immune response genes, while IL-4 activates repair and metabolic pathways.
- IMG cells show gene expression profiles similar to primary microglia under LPS stimulation.

## Abstract

In an attempt to identify markers that better characterize microglial states and to search for potential therapeutic targets, we performed a study using the IMG cell line as an in vitro microglial model. Specifically, we tested its response to several pro-inflammatory stimuli (lipopolysaccharide, interferon gamma, and tumor necrosis factor) and an anti-inflammatory stimulus (Interleukin-4) after 12 and 24 h of incubation. We performed RNA sequencing to identify genes modified at both incubation times (i.e., genes with sustained changes in the window between 12 and 24 h) that could reflect sustained microglial transcriptional responses. We also used Gene Ontology (GO) analysis to identify the most relevant pathways modified by these stimuli. RNA sequencing revealed four gene sets: (1) common genes that respond similarly to IL-4 and LPS, (2) specific LPS responders, (3) specific IL-4 responders, and (4) genes that exhibit LPS-induced upregulation and IL-4-induced downregulation, and vice versa (opposite responders). We hypothesize that the common gene set represents a general microglia response to pathological conditions, while the LPS- and IL-4-responder gene sets define specific microglial states under pro- and anti-inflammatory stimuli, respectively. We further propose that opposite responder genes act as metabolic switches between certain microglial states. The GO analysis indicated that LPS strongly upregulates biological processes related to the innate immune response, while IL-4 upregulates pathways related to repair, metabolic reprogramming, and cellular cooperation. Finally, the transcriptional response of IMG cells closely mirrored that of primary microglia, revealing highly similar gene expression and GO term profiles under LPS stimulation.

The online version contains supplementary material available at 10.1007/s12035-026-05711-4.

## Linked entities

- **Proteins:** IL4 (interleukin 4)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Lcn2 (lipocalin 2) [NCBI Gene 16819] {aka 24p3, NRL, Sip24}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Siglech (sialic acid binding Ig-like lectin H) [NCBI Gene 233274] {aka 6430529G09Rik, Siglec-H}, Nfkbia (nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha) [NCBI Gene 18035] {aka Nfkbi}, Mmp13 (matrix metallopeptidase 13) [NCBI Gene 17386] {aka Clg, MMP-13, Mmp1}, Raf1 (Raf1 proto-oncogene, serine/threonine kinase) [NCBI Gene 110157] {aka 6430402F14Rik, Craf1, D830050J10Rik, Raf-1, c-Raf, cRaf}, Mapk1 (mitogen-activated protein kinase 1) [NCBI Gene 26413] {aka 9030612K14Rik, ERK, Erk2, MAPK2, PRKM2, Prkm1}, Csf3 (colony stimulating factor 3 (granulocyte)) [NCBI Gene 12985] {aka Csfg, G-CSF, MGI-IG}, Cxcl3 (C-X-C motif chemokine ligand 3) [NCBI Gene 330122] {aka Dcip1, Gm1960}, Rnase2a (ribonuclease, RNase A family, 2A (liver, eosinophil-derived neurotoxin)) [NCBI Gene 93726] {aka Ear11}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 17533] {aka CD206, MR}, Pilra (paired immunoglobin-like type 2 receptor alpha) [NCBI Gene 231805] {aka FDF03}, Clec10a (C-type lectin domain family 10, member A) [NCBI Gene 17312] {aka CD301a, M-ASGP-BP-1, Mgl, Mgl1}, Serpinb1a (serine (or cysteine) peptidase inhibitor, clade B, member 1a) [NCBI Gene 66222] {aka 1190005M04Rik, EI, EIA, ELANH2, LEI, M/NEI}, Mapk3 (mitogen-activated protein kinase 3) [NCBI Gene 26417] {aka Erk-1, Erk1, Ert2, Esrk1, Mnk1, Mtap2k}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Galnt9 (polypeptide N-acetylgalactosaminyltransferase 9) [NCBI Gene 231605] {aka GalNAc-T9}, Il1a (interleukin 1 alpha) [NCBI Gene 16175] {aka Il-1a}, Cfb (complement factor B) [NCBI Gene 14962] {aka Bf, C2, Fb, H2-Bf}, Pianp (PILR alpha associated neural protein) [NCBI Gene 319352] {aka C530028O21Rik, Panp}, Cx3cl1 (C-X3-C motif chemokine ligand 1) [NCBI Gene 20312] {aka ABCD-3, CX3C, Cxc3, D8Bwg0439e, FK, Scyd1}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, H3f3a (H3.3 histone A) [NCBI Gene 15078] {aka EyeLinc14, H3-3a, H3-3b, H3.3A}, Ccl24 (C-C motif chemokine ligand 24) [NCBI Gene 56221] {aka CKb-6, MPIF-2, Scya24}, Sorbs3 (sorbin and SH3 domain containing 3) [NCBI Gene 20410] {aka SCAM-1, SH3P3, Sh3d4, vinexin-g}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Adgre1 (adhesion G protein-coupled receptor E1) [NCBI Gene 13733] {aka DD7A5-7, EGF-TM7, Emr1, F4/80, Gpf480, Ly71}, Saa3 (serum amyloid A 3) [NCBI Gene 20210] {aka Saa-3, l7R3}, Col4a1 (collagen, type IV, alpha 1) [NCBI Gene 12826] {aka Bru, Col4a-1, Raw, Svc}, Bex6 (brain expressed family member 6) [NCBI Gene 328660] {aka B020003O03Rik}, Tmem26 (transmembrane protein 26) [NCBI Gene 327766] {aka 3230401A06}, Megf10 (multiple EGF-like-domains 10) [NCBI Gene 70417] {aka 3000002B06Rik, Gm331}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Marco (macrophage receptor with collagenous structure) [NCBI Gene 17167] {aka Ly112, Scara2}, Scn5a (sodium channel, voltage-gated, type V, alpha) [NCBI Gene 20271] {aka Nav1.5, Nav1.5c, SkM1, SkM2, mH1}, Gpsm1 (G-protein signalling modulator 1 (AGS3-like, C. elegans)) [NCBI Gene 67839] {aka 1810037C22Rik, Ags3}, Ang2 (angiogenin, ribonuclease A family, member 2) [NCBI Gene 11731] {aka Angrp, Raa3, Rnase5b}, Mn1 (Mn1 proto-oncogene, transcriptional regulator) [NCBI Gene 433938], Chil3 (chitinase-like 3) [NCBI Gene 12655] {aka Chi3l3, ECF-L, Ym1}, Igf1 (insulin-like growth factor 1) [NCBI Gene 16000] {aka C730016P09Rik, Igf-1, Igf-I}, Il13 (interleukin 13) [NCBI Gene 16163] {aka Il-13}, Kbtbd11 (kelch repeat and BTB (POZ) domain containing 11) [NCBI Gene 74901] {aka 2900016B01Rik, 4930465M17Rik, mKIAA0711}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 19225] {aka COX2, Cox-2, PES-2, PGHS-2, PHS II, PHS-2}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Arg1 (arginase, liver) [NCBI Gene 11846] {aka AI, Arg-1, PGIF}, U90926 (cDNA sequence U90926) [NCBI Gene 57425], Klhl3 (kelch-like 3) [NCBI Gene 100503085] {aka 7530408C15Rik, EG627648}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Cbfa2t3 (CBFA2/RUNX1 translocation partner 3) [NCBI Gene 12398] {aka A630044F12Rik, Cbfa2t3h, ETO-2, Eto2, MTGR2}, Cish (cytokine inducible SH2-containing protein) [NCBI Gene 12700] {aka CIS-1, CIS1, Cis, F17, F23, SOCS}, Cmah (cytidine monophospho-N-acetylneuraminic acid hydroxylase) [NCBI Gene 12763], Gpr137c (G protein-coupled receptor 137C) [NCBI Gene 70713] {aka 6330416L11Rik, Gm908, TM7SF1L2}, Cx3cr1 (C-X3-C motif chemokine receptor 1) [NCBI Gene 13051] {aka mCX3CR1}, Mgl2 (macrophage galactose N-acetyl-galactosamine specific lectin 2) [NCBI Gene 216864] {aka CD301b}, Sting1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 72512] {aka 2610307O08Rik, ERIS, MPYS, Mita, STING, STING-beta}, Gm15764 (predicted gene 15764) [NCBI Gene 102638849], Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, H2-M5 (histocompatibility 2, M region locus 5) [NCBI Gene 240095] {aka CRW2, D130003B22Rik, H-2M5}
- **Diseases:** autosomal dominant cerebrovascular disease (MESH:D002561), neuroinflammation (MESH:D000090862), progressive supranuclear palsy (MESH:D013494), neurodegeneration (MESH:D019636), multiple system atrophy (MESH:D019578), traumatic brain injury (MESH:D000070642), stroke (MESH:D020521), dementia with Lewy bodies (MESH:D020961), frontotemporal dementia (MESH:D057180), PM (MESH:D010538), corticobasal degeneration (MESH:D000088282), AD (MESH:D000544), Parkinson's disease (MESH:D010300), age-related inflammation (MESH:D007249), arrhythmias (MESH:D001145), amyotrophic lateral sclerosis (MESH:D000690), APS (MESH:D016884), Huntington's disease (MESH:D006816)
- **Chemicals:** agarose (MESH:D012685), glucose (MESH:D005947), dTTP (MESH:C024157), dUTP (MESH:C027078), P/ (MESH:D010758), S (MESH:D013455), iron (MESH:D007501), sodium (MESH:D012964), glycosaminoglycan (MESH:D006025), 12LPS (-), NO (MESH:D009569), L-glutamine (MESH:D005973), nitrite (MESH:D009573), EDTA (MESH:D004492), streptomycin (MESH:D013307), penicillin (MESH:D010406), water (MESH:D014867), LPS (MESH:D008070), sulfur compound (MESH:D013457), Griess reagent (MESH:C095000), CO2 (MESH:D002245)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Escherichia coli O111:B4 (no rank) [taxon 1090940]
- **Cell lines:** BV2 — Mus musculus (Mouse), Transformed cell line (CVCL_0182), IMG — Homo sapiens (Human), Transformed cell line (CVCL_YJ42)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12881133/full.md

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12881133/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12881133/full.md

---
Source: https://tomesphere.com/paper/PMC12881133